top of page


Building a Next-Generation Medical Device Platform for India
"We combine global medtech operating experience with execution-led sourcing to build a scalable medical device platform in India—focused on chronic care, diagnostics, and advanced monitoring technologies including CGM"
India Market Focus
India represents one of the fastest-growing markets for chronic care and diabetes management. Medwisor is focused on expanding access to advanced medical technologies, including continuous glucose monitoring (CGM), through strong local execution and global partnerships.
Rising burden of chronic diseases, including diabetes, cardiovascular conditions, and respiratory disorders, driving sustained demand for monitoring and diagnostic devices
Fragmented distribution landscape, requiring execution-driven platforms to ensure reliability, availability, and scale.
Significant affordability gap between premium global products and local market needs, creating opportunity for cost-optimized, high-quality alternatives.
Increasing investment in healthcare infrastructure and digital health, supporting long-term growth across multiple device categories.
Rapid expansion of private hospitals, clinics, and diagnostic networks, accelerating adoption of modern medical technologies.
Strong shift toward home healthcare and remote monitoring, increasing demand for accessible, easy-to-use devices.
Medwisor is actively building partnerships with global manufacturers to bring differentiated, clinically validated devices to India through a scalable, execution-driven platform

About Medwisor.ai
Medwisor is building a medical device platform focused on the Indian market, combining global sourcing with deep operational experience in medtech manufacturing, supply chain, and strategic transactions.
Our work is grounded in execution. We have led supply chain due diligence for medtech acquisitions, built global engineering and sourcing organizations, and delivered large-scale operational transformations across regulated environments.
We are now applying that experience to build a scalable platform that brings clinically validated, cost-effective devices to India—while ensuring quality, compliance, and reliable supply at scale.
bottom of page